Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide, posing a major challenge to health systems. There are a variety of ...
Oligonucleotide (oligo) therapies have been in development for decades. Recent advances in molecular design, chemistry, ...
Pancreatic cancer research tackles treatment resistance with targeted drug delivery, immune-boosting combinations, and ...
RenovoRx, Inc., which is developing targeted oncology therapies and commercializing its FDA-cleared RenovoCath drug-delivery devi ...
Data Shows TAMP to be a Promising Approach for Local Delivery of Gemcitabine with Reduced Systemic Toxicity in Patients Diagnosed with Locally Advanced Pancreatic Cancer Metabolic Imaging, Used to ...
Peter Abbink, PhD, a Pace® Life Sciences expert, will serve as roundtable facilitator for the "Strategies for Targeted Drug ...
COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ — Lahjavida Bio, a biotechnology company pioneering a new class of tumor-targeted small ...
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will present new research at the American Association for Cancer Research (AACR) Annual Meeting, highlighting ...
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...
Peter Abbink, PhD, a Pace Life Sciences expert, will serve as roundtable facilitator for the "Strategies for Targeted Drug Delivery" session on April 30 in Boston BOSTON, MA / ACCESS Newswire / April ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results